Planned enrollment decreased by 21 participants
Before: 100 participants (planned). After: 79 participants (planned).
Primary completion date changed
Before: Jun 2026. After: Dec 2027.
Study sponsor: Edgewise Therapeutics, Inc. · EWTX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 100 participants (planned). After: 79 participants (planned).
Before: Jun 2026. After: Dec 2027.
Before: Recruiting. After: Active not recruiting.
Before: 75 participants (planned). After: 100 participants (planned).
Before: Mar 2026. After: Jun 2026.